title: The Golden Age in Cancer Nanobiotechnology: Quo Vadis?
authors.affiliation: Harvard-MIT Division for Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology , Cambridge, MA , USA.
authors.forename: João
authors.initials: J
authors.lastname: Conde
keywords: cancer nanotechnology; clinical trials as topic; in vivo models; medical devices; nanobiotechnology; nanomedicine; translational medical research